Exane Derivatives’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$160 Hold
2
﹤0.01% 692
2022
Q1
$226 Hold
2
﹤0.01% 952
2021
Q4
$228 Hold
2
﹤0.01% 832
2021
Q3
$233 Hold
2
﹤0.01% 1003
2021
Q2
$243 Sell
2
-34
-94% -$4.02K ﹤0.01% 1007
2021
Q1
$3.88K Sell
36
-4,125
-99% -$458K ﹤0.01% 635
2020
Q4
$488K Sell
4,161
-1,594
-28% -$162K 0.14% 160
2020
Q3
$493K Buy
5,755
+115
+2% +$9.82K 0.14% 132
2020
Q2
$446K Buy
+5,640
New +$440K 0.12% 151

Other funds holding DVA

Exane Derivatives's DVA Position: Q2 2022 in Review

Exane Derivatives held its DaVita (DVA) position steady in Q2 2022 at 2 shares worth $160. The position accounts for ﹤0.01% of the portfolio, ranked #692.

Exane Derivatives first reported a position in DVA in Q2 2020 and has held it in 9 quarters since. The position peaked at $493K in Q3 2020. 462 funds tracked by Wall St. Rank hold DVA as of Q2 2022.

  • Exane Derivatives held 2 shares of DaVita worth $160 as of Q2 2022.
  • Exane Derivatives left its DaVita share count unchanged in Q2 2022.
  • DaVita made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #692 holding.
  • Exane Derivatives first reported a position in DaVita in Q2 2020 and has held it in 9 quarters since.
  • Exane Derivatives's DaVita position peaked at $493K in Q3 2020.
  • 462 funds tracked by Wall St. Rank held DaVita as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.